Quick Answer
International Stem Cell CORP reported Diluted EPS of $0.05 per share (loss) for fiscal year 2025.
International Stem Cell CORP Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.05 | -66.7% |
| 2024 | -$0.03 | -50.0% |
| 2023 | -$0.02 | +50.0% |
| 2022 | -$0.04 | +63.6% |
| 2021 | -$0.11 | +66.7% |
| 2018 | -$0.33 | +77.4% |
| 2017 | -$1.46 | -329.4% |
| 2016 | -$0.34 | +85.0% |
| 2015 | -$2.26 | +78.1% |
| 2014 | -$10.34 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | +100.0% | -100.0% |
| June 30, 2025 | $0.01 | +0.0% | +133.3% |
| March 31, 2025 | -$0.03 | +0.0% | -50.0% |
| September 30, 2024 | -$0.02 | +0.0% | -300.0% |
| June 30, 2024 | $0.01 | -66.7% | +133.3% |
| March 31, 2024 | -$0.03 | — | -50.0% |
| September 30, 2023 | -$0.02 | +50.0% | -166.7% |
| June 30, 2023 | $0.03 | — | — |
- International Stem Cell CORP showed a decrease of -66.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2014–2025 period, International Stem Cell CORP’s diluted eps has grown by 99.5% (from $10.34 per share (loss) to $0.05 per share (loss)).
- The most recent figure is from International Stem Cell CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: